| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8c72929deb0d5e6041dd021d8ab6e90 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2960775-A1 |
| titleOfInvention |
MICROGRANULES RESISTANT TO MISMATCH |
| abstract |
The subject of the invention is the use of an oral pharmaceutical form based on microgranules to reduce the misuse of at least one active principle that it contains. The object of the present invention is to prevent the diversion of an oral pharmaceutical form based on microgranules containing at least one active ingredient that can create a dependency, a gelling agent and a gelling activator. The gelling agent and the activator are brought into contact only in the event of crushing bypass. This pair of excipients chooses judiciously confers on the formulation a viscosity such that said formulation can not be administered by injection or does not release the active ingredient rapidly by forming a gel in contact with the mucosa if administered nasally. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792254-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959958-B2 |
| priorityDate |
2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |